Mid-Atlantic Bio

Sep 01, 2010

Your Success Is Our Priority

If you follow Mid-Atlantic Bio through Facebook, LinkedIn or Twitter, chances are, you already have a networking foothold in the biotech industry. Gain traction and meet the right contacts in person by taking the next step: attend the 2010 Mid-Atlantic Bio Conference, October 27-29, in Bethesda, MD.

Now in its sixth year, the Mid-Atlantic Bio conference has a proven track record for providing ROI through targeted networking, business expansion, and technical-knowledge sharing. We understand that, especially in these economic times, every dollar spent must yield value to you and your organization. As an attendee at the conference, you can expect to connect with the right people, build relationships and learn from:

• Senior executives from more than 200 companies
• Key representatives from more than 50 investment funds
• Senior faculty from the region’s top academic and research institutions
• Attendees from more than 30 states and numerous countries around the world

This year’s conference program also features leaders in the life sciences field who will share their success stories.

2010 Program Highlights

NIH Welcome Reception

• Behind-the-scenes campus tour at the NIH
• Networking in a casual environment with some of the most influential leaders in bioscience, including featuring Dr. Francis Collins (invited)

Keynote Presentations

• Frederick Frank, Vice Chairman, Peter J. Solomon Company
• Martine A. Rothblatt, PhD, JD, MBA, Chairman and CEO of United Therapeutics Corporation
• Joshua M. Sharfstein, M.D., Principal Deputy Commissioner, U.S. Food and Drug Administration
• H. Thomas Watkins, President and Chief Executive Officer, Human Genome Sciences

Conference Sessions

• An Insider’s View on Washington
• Synthetic Biology – Applications and Implications
• Accessing the Regulatory Risk: Your Path to Approval
• CEO Roundtable
• Selected companies from the full spectrum of sectors and stages within the life sciences community will showcase their technologies

Networking Opportunities

• An exclusive CEO-Investor Reception at MedImmune headquarters
• Signature BioMatch Program offering the opportunity to check out who’s coming and schedule one-on-one meetings with other Mid-Atlantic Bio participants in advance
• Special Interest Groups Breakfast, featuring topics such as Global Collaboration and Expansion, Identifying and Securing Federal Grants and Contracts, and Understanding the Constant Regulatory Hurdles and How they Impact Day-to-Day Research

We look forward to seeing you there!